SCHEMBL7809783

SCHEMBL7809783

CC(C)(Oc1ccc(N2CCN(C(=O)c3c[nH]c4ccccc34)CC2)cc1)C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GFER P55789 1/20 0.70
LMNA P02545 3/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HTT P42858 3/20 0.52
MAPK14 Q16539 1/20 0.52
DRD2 P14416 1/20 0.52
DRD3 P35462 1/20 0.52
ITGB3 P05106 1/20 0.50
ITGA2B P08514 1/20 0.50
ALDH1A1 P00352 6/20 0.49
MAPT P10636 6/20 0.48
MEN1 O00255 4/20 0.48
KMT2A Q03164 4/20 0.48
USP2 O75604 2/20 0.48
GAA P10253 1/20 0.48
RAB9A P51151 1/20 0.48
NPSR1 Q6W5P4 2/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
RECQL P46063 1/20 0.45
PPARD Q03181 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7811443 0.90 GFER (0.67) GFERLMNASMN1; SMN2HTTMAPK14
SCHEMBL7809931 0.84 TPSAB1 (0.56) GFERHTTMAPK14DRD2DRD3
SCHEMBL7810111 0.84 GFER (0.60) GFERLMNASMN1; SMN2HTTMAPK14
SCHEMBL8445235 0.83 GFER (1.00) GFERLMNAHTTMAPK14DRD2
SCHEMBL7817559 0.82 ITGB3 (0.56) LMNASMN1; SMN2HTTITGB3ITGA2B
SCHEMBL24358707 0.81 GFER (0.81) GFERLMNASMN1; SMN2HTTMAPK14
SCHEMBL7811324 0.81 MAPT (0.58) GFERLMNASMN1; SMN2HTTMAPK14
SCHEMBL23259093 0.80 GFER (0.83) GFERLMNASMN1; SMN2HTTMAPK14
SCHEMBL7811736 0.80 ITGB3 (0.64) LMNAHTTDRD2ITGB3ITGA2B
SCHEMBL7804291 0.78 TPSAB1 (0.63) GFERHTTMAPK14DRD2DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed